Home LiteratureArticle Details
PMID: 18451155 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Pten haploinsufficiency accelerates formation of high-grade astrocytomas.

Cancer research ·Vol. 68 ·No. 9 ·2008-05-01 ·Pages 3286-94

Kwon CH, Zhao D, Chen J, Alcantara S, Li Y, Burns DK, Mason RP, Lee EY, Wu H, Parada LF

Abstract

We previously reported that central nervous system (CNS) inactivation of Nf1 and p53 tumor suppressor genes in mice results in the development of low-grade to high-grade progressive astrocytomas. When the tumors achieve high grade, they are frequently accompanied by Akt activation, reminiscent of the frequent association of PTEN mutations in human high-grade glioma. In the present study, we introduced CNS heterozygosity of Pten into the Nf1/p53 astrocytoma model. Resulting mice had accelerated morbidity, shortened survival, and full penetrance of high-grade astrocytomas. Haploinsufficiency of Pten accelerated formation of grade 3 astrocytomas, whereas loss of Pten heterozygosity and Akt activation coincided with progression into grade 4 tumors. These data suggest that successive loss of each Pten allele may contribute to de novo formation of high-grade astrocytoma and progression into glioblastoma, respectively, thus providing insight into the etiology of primary glioblastoma. The presence of ectopically migrating neural stem/progenitor lineage cells in presymptomatic Pten-deficient mutant brains supports the notion that these tumors may arise from stem/progenitor cells.

MeSH Terms
Animals Astrocytoma/genetics,pathology Brain Neoplasms/genetics,pathology Cell Movement/genetics Cell Survival Disease Progression Female Genes, Neurofibromatosis 1 Genes, p53 Loss of Heterozygosity/physiology Male Mice Mice, Inbred C57BL Mice, Inbred CBA Mice, Transgenic Neurons/pathology Oncogene Protein v-akt/metabolism PTEN Phosphohydrolase/genetics Stem Cells/physiology
Chemicals
Oncogene Protein v-akt PTEN Phosphohydrolase Pten protein, mouse
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Kwon Chang-Hyuk
Department of Developmental Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9133, USA.
Zhao Dawen
Chen Jian
Alcantara Sheila
Li Yanjiao
Burns Dennis K
Mason Ralph P
Lee Eva Y-H P
Wu Hong
Parada Luis F
References (49)
49 references, click to expand
  1. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.
    Genesis. 2001 Oct;31(2):85-94 PMID: 11668683
  2. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
    Cancer Res. 2006 Aug 1;66(15):7473-81 PMID: 16885344
  3. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    J Neuropathol Exp Neurol. 2005 Jun;64(6):479-89 PMID: 15977639
  4. Identification of a cancer stem cell in human brain tumors.
    Cancer Res. 2003 Sep 15;63(18):5821-8 PMID: 14522905
  5. Origin of oligodendrocytes in the subventricular zone of the adult brain.
    J Neurosci. 2006 Jul 26;26(30):7907-18 PMID: 16870736
  6. High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.
    Cancer Res. 2006 Aug 1;66(15):7429-37 PMID: 16885338
  7. Neuron-specific enolase-cre mouse line with cre activity in specific neuronal populations.
    Genesis. 2006 Mar;44(3):130-5 PMID: 16496331
  8. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.
    Cancer Cell. 2005 Aug;8(2):119-30 PMID: 16098465
  9. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Cancer Res. 2002 Oct 1;62(19):5551-8 PMID: 12359767
  10. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain.
    Cell. 1999 Jun 11;97(6):703-16 PMID: 10380923
  11. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.
    Nat Genet. 2000 May;25(1):55-7 PMID: 10802656
  12. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
    Cell. 1998 Oct 2;95(1):29-39 PMID: 9778245
  13. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    J Biol Chem. 1998 May 29;273(22):13375-8 PMID: 9593664
  14. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A.
    Science. 1997 May 2;276(5313):791-4 PMID: 9115203
  15. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.
    Science. 2001 Dec 7;294(5549):2186-9 PMID: 11691952
  16. Genetic pathways to glioblastoma: a population-based study.
    Cancer Res. 2004 Oct 1;64(19):6892-9 PMID: 15466178
  17. Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation.
    Cancer Cell. 2002 Mar;1(2):157-68 PMID: 12086874
  18. TrkB has a cell-autonomous role in the establishment of hippocampal Schaffer collateral synapses.
    J Neurosci. 2005 Apr 13;25(15):3774-86 PMID: 15829629
  19. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection.
    Cell. 2002 Apr 5;109(1):75-86 PMID: 11955448
  20. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
    Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5 PMID: 10200246
  21. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Cancer Res. 2005 Mar 15;65(6):2065-9 PMID: 15781613
  22. Differential expression of Rho family GTP-binding proteins and protein kinase C isozymes during C6 glial cell differentiation.
    Brain Res Mol Brain Res. 1997 Apr;45(1):90-8 PMID: 9105674
  23. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
    Neoplasia. 2005 Apr;7(4):356-68 PMID: 15967113
  24. A unified hypothesis on the lineage of neural stem cells.
    Nat Rev Neurosci. 2001 Apr;2(4):287-93 PMID: 11283751
  25. Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner.
    Cancer Res. 2006 Feb 15;66(4):1929-39 PMID: 16488991
  26. Pten is essential for embryonic development and tumour suppression.
    Nat Genet. 1998 Aug;19(4):348-55 PMID: 9697695
  27. Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation.
    Cancer Res. 2005 Jun 15;65(12):5172-80 PMID: 15958561
  28. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.
    J Biol Chem. 1997 Jan 31;272(5):2927-35 PMID: 9006938
  29. Neurofibromin, a tumor suppressor in the nervous system.
    Exp Cell Res. 2001 Mar 10;264(1):19-28 PMID: 11237520
  30. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Nat Genet. 2000 Sep;26(1):109-13 PMID: 10973261
  31. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.
    Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1563-8 PMID: 9990064
  32. The molecular and genetic basis of neurological tumours.
    Nat Rev Cancer. 2002 Aug;2(8):616-26 PMID: 12154354
  33. Cancerous stem cells can arise from pediatric brain tumors.
    Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83 PMID: 14645703
  34. Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo.
    Cancer Res. 2004 Nov 1;64(21):7773-9 PMID: 15520182
  35. Pten regulates neuronal arborization and social interaction in mice.
    Neuron. 2006 May 4;50(3):377-88 PMID: 16675393
  36. Mammalian neural stem cells.
    Science. 2000 Feb 25;287(5457):1433-8 PMID: 10688783
  37. Malignant glioma: genetics and biology of a grave matter.
    Genes Dev. 2001 Jun 1;15(11):1311-33 PMID: 11390353
  38. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
    Cancer Res. 2001 May 1;61(9):3826-36 PMID: 11325859
  39. Timing of p53 mutations during astrocytoma tumorigenesis.
    Hum Mol Genet. 1993 Oct;2(10):1687-90 PMID: 8268922
  40. Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas.
    Lab Invest. 1998 Feb;78(2):165-74 PMID: 9484714
  41. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.
    Cancer Cell. 2003 Feb;3(2):117-30 PMID: 12620407
  42. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
    Cancer Cell. 2006 Mar;9(3):157-73 PMID: 16530701
  43. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
    Cancer Res. 2004 May 15;64(10):3525-32 PMID: 15150107
  44. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.
    Glia. 2002 Sep;39(3):193-206 PMID: 12203386
  45. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.
    J Natl Cancer Inst. 1999 Nov 17;91(22):1922-32 PMID: 10564676
  46. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons.
    Neuron. 1999 Jun;23(2):257-71 PMID: 10399933
  47. Tumor spectrum analysis in p53-mutant mice.
    Curr Biol. 1994 Jan 1;4(1):1-7 PMID: 7922305
  48. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
    N Engl J Med. 2005 Mar 10;352(10):987-96 PMID: 15758009
  49. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.
    Curr Biol. 1998 Oct 22;8(21):1169-78 PMID: 9799734
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
1538-7445
Published
2008-05-01
Pages
3286-94
Language
English
Region
United States
NLM ID
2984705R
PMCID
PMC2760841
Subset
IM
Grants
NCRR NIH HHS · P41 RR002584 · United States
NCI NIH HHS · U24 CA126608-01 · United States
NCI NIH HHS · U24CA126608 · United States
NCRR NIH HHS · P41-RR02584 · United States
NINDS NIH HHS · P50 NS052606-05 · United States
NINDS NIH HHS · R37 NS033199-10 · United States
NINDS NIH HHS · R37NS33199 · United States
NCI NIH HHS · U24 CA126608 · United States
NINDS NIH HHS · R37 NS033199 · United States
NINDS NIH HHS · P50 NS052606 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com